Rechallenging MCT11 blockade CRs after 1 month, in the absence of any additional therapy, resulted in tumor clearance, suggesting the MCT11 blockade resulted in the formation of immunologic memory (Fig. 4n,o). Here, SLC16A11 is linked to neoplasm.